Stigmasterol alleviates airway inflammation in OVA-induced asthmatic mice via inhibiting the TGF-β1/Smad2 and IL-17A signaling pathways
Aging · 2024
DOI: 10.18632/aging.205716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Sihong Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shanghai Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Tradition…. Hauptthemen laut MEDLINE: Asthma, Smad2 Protein, Transforming Growth Factor beta1, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Shanghai Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201999, China.
Zitieren
APA
Huang, S., Zhou, R., Yuan, Y., & Shen, Y. (2024). Stigmasterol alleviates airway inflammation in OVA-induced asthmatic mice via inhibiting the TGF-β1/Smad2 and IL-17A signaling pathways. Aging. https://doi.org/10.18632/aging.205716
Vancouver
Huang S, Zhou R, Yuan Y, Shen Y. Stigmasterol alleviates airway inflammation in OVA-induced asthmatic mice via inhibiting the TGF-β1/Smad2 and IL-17A signaling pathways. Aging. 2024. doi:10.18632/aging.205716
BibTeX
@article{Huang2024,
author = {Huang, Sihong and Zhou, Rong and Yuan, Yuyun and Shen, Yiyun},
title = {Stigmasterol alleviates airway inflammation in OVA-induced asthmatic mice via inhibiting the TGF-β1/Smad2 and IL-17A signaling pathways},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205716}
}
EUVIMED